MetaCap

Akebia Therapeutics (AKBA) News

NASDAQ: AKBAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.3855-0.0368 (-8.71%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

AKBA news summary

We found 8 recent headlines mentioning Akebia Therapeutics (AKBA): 3 in the past week and 8 in the past 30 days, most often from GlobeNewswire, Nasdaq. AKBA is making an outsized move today, down 8.71% at $0.3855, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Akebia Therapeutic’s Vafseo® (vadadustat) Granted Additional Patent", was published by GlobeNewswire on Nov 17, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Akebia Therapeutics headlines

Compare AKBA